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Abstract 
Background:  Giant cell arteritis (GCA) is 
the commonest of the vasculitides and should form 
part of the differential diagnosis of a new-onset 
headache in patients over 50 years with elevated 
inflammatory markers.  Temporal artery biopsy 
(TAB) is the gold standard for its diagnoses. 
Aim:   The aim of this audit was to 
determine whether patients referred for a TAB 
between 2010 and 2015 at Mater Dei Hospital 
qualified for a diagnosis of GCA and the 
significance of the TAB result in affecting 
management of GCA by correlating the clinical 
profile and biochemical criteria according to the 
guidelines based on the American College of 
Rheumatology (ACR) criteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results: The percentage of positive TABs in 
our cohort of 170 patients was 23%. The ESR 
(sensitivity - 100%) was shown to be a significant 
factor associated with a positive TAB when 
compared to CRP (sensitivity 90%). 79.5% of 
positive TAB results were patients aged between 
70-89 years of age, proving age is also a significant 
factor. New onset headache was the most common 
complaint (66%). Only 45.9% of patients were 
started on steroids prior to TAB despite the clinical 
suspicion of GCA.  This increased to 54.1% of 
patients on steroids after TAB was performed, 
pending a histology result. 
Conclusion:  Our findings, which are similar 
to comparing studies, question the practicality of 
TAB in the clinical diagnosis of GCA. Clinical 
symptoms, raised ESR and increasing age proved to 
be significant factors contributing to the clinical 
diagnosis and management of GCA. Non-invasive 
ultrasonography can further confirm the diagnosis 
and is to replace TAB in the near future. 
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Introduction 
Giant cell arteritis (GCA), also known as 
temporal arteritis, is a chronic systemic vasculitis of 
unknown aetiology, usually occurring in older 
people, affecting medium and large arteries, leading 
to a variety of complications if not promptly treated.  
GCA predominantly affects branches of the external 
carotid artery.  Histopathologically, it is a 
granulomatous inflammation of the affected vessels 
with eventual arterial luminal narrowing and distal 
ischaemia.1 
GCA is the commonest of all the vasculitides 
and should form part of the differential diagnosis of 
new-onset headache in patients over 50 years of age 
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with elevated inflammatory markers. The reported 
incidence of GCA is between 7 and 29/100,000 in 
Europe for people aged more than 50 years. 2   The 
condition is a common cause of acute blindness, 
with visual loss occurring in up to one-fifth of 
patients, thus making it a medical emergency 
requiring prompt initiation of treatment. Moreover, 
it is one of the commonest indications for long-term 
glucocorticoid use in the community.3-5 
GCA is often managed both in the community 
by general practitioners and in secondary care by 
rheumatologists, ophthalmologists and other 
specialists thus further emphasizing the importance 
of formulating guidelines in order to ensure proper 
quality care. Temporal artery biopsy is currently the 
gold standard for diagnosis of GCA.6 
 
Guidelines 
The guidelines used for this audit as a 
standard for comparing our data were the British 
Society of Rheumatology (BSR) and the British 
Health Professionals in Rheumatology (BHPR) 
guidelines for the management of GCA based on 
the American College of Rheumatology (ACR), 
published in 1990.  
The ACR classification criteria for diagnosing 
GCA is if at least three of five of the criteria listed 
below are present: 
1. Age at disease onset ≥50 years: development 
of symptoms or findings beginning at the age 
of 50 years.  
2. New onset headache 
3. Temporal artery tenderness to palpation or 
decreased pulsation, unrelated to 
arteriosclerosis of cervical arteries 
4. Elevated ESR: ESR ≥50 mm/h according to 
the Westergren method 
5. Abnormal artery biopsy: biopsy specimen 
with artery showing vasculitis characterized 
by a predominance of mononuclear cell 
infiltration or granulomatous inflammation, 
usually with multinucleated giant cells.  
Aim 
The aim of this audit was to determine: 
1) Whether patients referred for a temporal artery 
biopsy between 2010 and 2015 qualified for a 
diagnosis of GCA 
2) The significance of a temporal artery biopsy 
result in affecting management of giant cell 
arteritis by correlating the clinical profile and 
biochemical criteria associated with a positive 
histology obtained from a temporal artery 
biopsy  
Methodology 
Permission was obtained from the 
Chairperson of Surgery and the Data Protection 
Unit in Mater Dei Hospital prior to data collection.  
The time period for patients included in this audit 
was between 2010 and 2015.   
Patients who underwent temporal artery 
biopsy in the Mater Dei Hospital Surgical Theatres 
were included in the study.  iSOFT clinical 
Manager and discharge letters were used for data 
collection.  A proforma was used for data 
collection.  Patient demographics, clinical 
indication for temporal artery biopsy, histological 
results, ESR and CRP were collected for the 
patients.  
The data collected was then compared to the 
BSR and BHPR guidelines for the management of 
Giant Cell Arteritis, based on the American College 
of Rheumatology 1990 criteria. 
 
Results 
A total of 201 patients were identified from 
the Surgical Theatre Logbooks.  170 patients (55 
males vs. 115 females) were included in the audit 
after patients without availability of ESR, CRP or 
temporal artery biopsy results were excluded. The 
mean age of the patients was 74.34 years (range 55 
to 97 years).   
Figure 1 shows the age distribution of the 
patients included in the audit.  
 
Figure 1:  Age Distribution 
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As shown in Figure 2, 131 (77%) patients had 
a negative TAB result compared to 39 (23%) 
patients with a positive TAB result.  The average 
length of the branch of temporal artery sent for 
histology was 8.3mm.  The length ranged from 
2mm to 21mm.  145 (85% of the total population 
studied) patients had a TAB specimen of 5mm or 
longer.  111 (76.55%) of patients with a TAB 
biopsy of >5mm was negative for a temporal artery 
diagnosis, whilst 34 (23.45%) of patients with a 
TAB biopsy <5mm was positive for a temporal 
artery diagnosis. 25 (15% of the total population) 
had a TAB specimen less than 5mm, with 20 of the 
patients having a negative TAB and 5 patients with 
a specimen less than 5mm had a positive TAB 
result.  
 
Figure 2:  Temporal artery biopsy result 
 
 
 
 
 
 
 
 
 
 
 
 
 
The average ESR result was 72.60mm/hr.  
Figure 3 shows the distribution of the ESR results 
in the patients included. 
 
Figure 3: ESR Distribution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: CRP Distribution 
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Figure 5: Patients’ Symptoms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Sensitivity, Specificity, PPV and NPV results 
Parameter Sensitivity Specificity PPV NPV 
ESR value >10  100.00% 3.05% 23.49% 100.00% 
ESR value >100  25.64% 78.81% 23.26% 77.17% 
CRP >6  90.00% 35.88% 30.00% 92.16% 
CRP >100  41.03% 90.08% 55.17% 83.69% 
ESR and CRP positive 94.81% 21.76% 26.26% 93.44% 
Headache present 64.86% 30.00% 20.87% 75.00% 
Jaw Claudication 21.62% 86.05% 30.77% 79.29% 
Visual Symptoms 36.84% 64.12% 22.95% 77.78% 
Headache, jaw, visual symptoms present 25.00% 79.41% 30.00% 75.00% 
Symptoms and inflammatory markers >50  100.00% 76.47% 42.86% 100.00% 
 
The average CRP result was 54.42 (range 6 to 
320).  The distribution of the CRP result is shown 
in Figure 4. 
The most common symptom for which TAB 
was performed was for new onset headaches (60% 
of patients).  Figure 5 shows the different symptoms 
reported by patients undergoing TAB procedure. 
Sensitivity and specificity rates for TAB 
positive results were calculated  in relation to 
variables. Positive predictive value (PPV) and  
negative predictive values (NPV) were also 
calculated for different parameters (Table 1). 
Steroids administration to patients following 
the TAB procedure was recorded.  78 (45.9%) 
patients had steroids prescribed prior to the TAB 
procedure whilst 76 (44.7%) patients did not have 
steroids prescribed prior to the TAB procedure.  No 
information was found for 16 (9.4%) patients.  
Following the TAB histopathological result, 
steroids were stopped in 49 (28.90%) patients.  
Steroids were continued in 92 (54.10%) patients.   
 
Discussion 
In our cohort of 170 patients undergoing 
temporal artery biopsy, patients with an ESR >10 
had a positive TAB with a sensitivity of a 100%.  A 
CRP value less than 6 was sensitive in 90% of cases 
with a positive TAB. This shows that ESR is an 
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important significant factor associated with a 
positive histological diagnosis of GCA when 
compared to CRP. 
Positive TAB results were seen in 39 patients, 
79.5% of which were patients aged between 70-89 
years of age. Such a result shows that age is a 
significant factor associated with a positive TAB 
result.  These results mirror a similar study outcome 
by Saedon et al.  The authors in this study 
concluded that ESR and age are the two important 
significant factors associated with a positive 
histological diagnosis of GCA.7 This was compared 
to a previous study by Kernani et al. which showed 
that elevated CRP provided a sensitivity of 87% for 
a positive TAB when compared to an elevated ESR 
which had a sensitivity of 86%.8   Our audit 
suggests that ESR still has an important role in the 
work-up of GCA and may be superior to CRP in 
predicting a positive TAB. 
A variety of symptoms were reported by the 
patients undergoing a TAB, with new onset 
headache being the most common complaint in 
66% of patients.  A positive TAB with new onset 
headache was reported in 25 patients (14.71%) of 
the patient population. The sensitivity was 64.86%, 
however a negative predictive value of 75% was 
seen, indicating that there is a 75% chance of 
having a positive TAB without a headache.  A 
sensitivity of only 25% was seen in patients who 
reported headaches, jaw claudication and visual 
symptoms collectively, with a negative predictive 
value of 75% of more seen both in the cohort of 
patients who reported the triad of symptoms, or in 
those patients who had individual symptoms.  This 
shows that there was at least a 75% chance of 
having a positive TAB without any of these 
symptoms.  
In our study, the average length of the branch 
of temporal artery sent for histology was 8.3mm 
with a range from 2mm to 21mm.  85% of TAB 
specimen had a biopsy length of 5mm or more; 
76.55% of which had a negative TAB whilst 
23.45% had a positive TAB. The other 20 cases had 
a biopsy length of less than 5mm, 80% of which 
had a negative TAB with 20% having a positive 
TAB. This shows that TAB length did not 
significantly correlate with a positive histology 
result. This is in conflict with previous studies.  
Mahret al. identified 5mm as the TAB length for 
diagnostic sensitivity9 whilst Ypsilantis et al. 
identified that 7mm is the cut-off length with the 
highest positive predictive value for a positive 
biopsy.10   Moreover, Su et al. recommend a length 
of at least 12.5mm to allow for artery contraction 
following tissue fixation.11 
Recent guidelines by the British Society for 
Rheumatology and British Health Professionals in 
Rheumatology for the management of GCA 
recommend that high-dose glucocorticosteroid 
therapy should be initiated immediately when 
clinical suspicion of GCA is raised.2   In our study, 
only 45.9% of patients were started on steroids 
prior to TAB despite the clinical suspicion of GCA.  
This increased to 54.1% of patients on steroids after 
TAB was performed with a pending histology 
result.   
The percentage of positive TABs in our cohort 
was 23%.  Similarly, Saedon et al.’s study 
involving 153 patients found a positive TAB in 
29% of patients 7 whilst Mahret al,’s study included 
1520 patients with only 15% resulting in a positive 
TAB.9  These findings question the practicality of 
TAB in the clinical diagnosis of GCA in view of the 
low percentage of positive biopsies seen in our 
study and similar results in other studies with a high 
proportion of patients with negative biopsies in our 
study still being treated as GCA, based on clinical 
symptoms and inflammatory markers.  
The role of TAB is starting to be replaced by 
colour duplex ultrasonography which is a new, 
noninvasive method to diagnose GCA whilst 
reducing the chances of false-negative biopsies due 
to skip lesions.12   Other imaging modalities such as 
positron emission tomography and three tesla-
magnetic resonance imaging are also being used in 
other centres.13-14 
 
Limitations 
This audit was done retrospectively based on 
observational data.  Therefore, it is limited by 
possible inconsistent record keeping.   This might 
have influenced the data regarding the initiation of 
steroid treatment prior to TAB for a presumptive 
diagnosis of GCA and steroid treatment pending 
biopsy result.  Another limitation to this audit was 
the level of specialization of the surgeon performing 
the TAB. Despite this, similar clinical and 
biochemical criteria associated with a positive TAB 
were found in other studies.  
 
Conclusion 
From this study, it is evident that it would be 
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practical to reduce the number of TAB performed if 
there was sufficient clinical suspicion of GCA to 
commence treatment. Clinical symptoms as well as 
a raised ESR, are significant factors contributing to 
the clinical diagnosis of GCA. Diagnosis can be 
further confirmed by ultrasonography as a non-
invasive methodology to replace TAB in the near 
future. 
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